LeBuhn Richard T. 4

What Happened

• Richard T. LeBuhn, a director of STAAR Surgical Company (STAA), received a grant of 11,145 stock options on June 18, 2026. The filing reports the award as a derivative acquisition at $0.00 (no cash paid at grant). This is a compensation grant, not an open-market purchase or sale.

Key Details

• Transaction date: June 18, 2026; Form 4 filed June 22, 2026 (appears timely; Form 4s are generally due within two business days).
• Transaction type: Award/Grant of derivative securities (options).
• Quantity: 11,145 options; reported consideration: $0.00.
• Vesting/terms: Footnote F1 — options vest on the earlier of (a) June 18, 2027 or (b) the Issuer’s next annual meeting of shareholders, subject to continuous service. Footnote F2 — granted as director compensation under the company’s Amended and Restated Omnibus Equity Incentive Plan. Footnote F3 — the filing also states these options are currently exercisable.
• Shares owned after transaction: not specified in the provided filing.

Context

• This was an options award (derivative grant). Awards like this are routine director compensation and do not by themselves change share ownership until the options are exercised. Because no exercise or sale occurred, there is no immediate cash flow or change in publicly tradable shares tied to this Form 4.